L Camoin-Jau
Overview
Explore the profile of L Camoin-Jau including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
408
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Camoin-Jau L, Mariotti A, Suchon P, Morange P
Rev Med Interne
. 2021 Sep;
43(1):18-25.
PMID: 34535328
Heparin-induced thrombocytopenia (HIT) is a serious complication of heparin therapy. It is due to the synthesis of antibodies most often directed against platelet factor 4 (FP4) modified by heparin (H)....
2.
Barbieri R, Mai B, Chenal T, Bassi M, Gandia D, Camoin-Jau L, et al.
Sci Rep
. 2020 Jun;
10(1):10069.
PMID: 32572066
Photogrammetry and cascading microscopy investigations of dental pulp specimens collected from 2,000-year-old individuals buried in a Roman necropolis in Besançon, France, revealed unprecedented preserved tissular and cellular morphology. Photogrammetry yielded...
3.
Gaubert M, Resseguier N, Laine M, Bonello L, Camoin-Jau L, Paganelli F
J Thromb Haemost
. 2017 Dec;
16(3):465-473.
PMID: 29274198
Summary: Background Dual antithrombotic therapy comprising a vitamin K antagonist (VKA) plus clopidogrel reduces the incidence of major bleeding compared with triple therapy (VKA + clopidogrel + aspirin) in acute...
4.
Bonello L, Laine M, Camoin-Jau L, Frere C
J Thromb Haemost
. 2017 Apr;
15(7):1522-1523.
PMID: 28426920
No abstract available.
5.
Bonello L, Mancini J, Pansieri M, Maillard L, Rossi P, Collet F, et al.
J Thromb Haemost
. 2012 Aug;
10(10):1999-2005.
PMID: 22863374
Background: Post-treatment platelet reactivity (PR) is associated with ischemic and bleeding events in patients receiving P2Y12 receptor antagonists. Objectives: We aimed to study the relationship between post-treatment PR after a...
6.
Bonello L, Bonello N, Grosdidier C, Camoin-Jau L
Clin Pharmacol Ther
. 2011 Nov;
90(6):774-6.
PMID: 22089343
Clopidogrel is an important antiplatelet agent, but a considerable variability in the biological effect of the drug has been observed. Additionally, patients with insufficient platelet reactivity inhibition following a loading...
7.
Sabatier F, Lacroix R, Camoin-Jau L, Anfosso F, Sampol J, Dignat-George F
Rev Med Interne
. 2010 Jun;
32(1):54-63.
PMID: 20541851
Exposure to deleterious processes of metabolic, infectious, autoimmune or mechanical origin, alters the endothelium which progresses towards a proinflammatory and procoagulant activation, senescence and apoptosis. This "response to injury" of...
8.
Jourde-Chiche N, Dou L, Sabatier F, Calaf R, Cerini C, Robert S, et al.
J Thromb Haemost
. 2009 Jul;
7(9):1576-84.
PMID: 19583820
Background: Patients suffering from chronic kidney diseases (CKD) exhibit cardiovascular diseases and profound endothelial dysfunction. CKD patients have reduced numbers of endothelial progenitor cells, but little is known about the...
9.
Sabatier F, Camoin-Jau L, Anfosso F, Sampol J, Dignat-George F
J Cell Mol Med
. 2009 Apr;
13(3):454-71.
PMID: 19379144
The balance between lesion and regeneration of the endothelium is critical for the maintenance of vessel integrity. Exposure to cardiovascular risk factors (CRF) alters the regulatory functions of the endothelium...
10.
Al-Massarani G, Vacher-Coponat H, Paul P, Arnaud L, Loundou A, Robert S, et al.
Am J Transplant
. 2009 Mar;
9(3):550-7.
PMID: 19260834
Microparticles (MP) are important players in cardiovascular disorders. Renal transplantation significantly improves the survival of hemodialyzed patients, in part because cardiovascular disease (CVD) progression is lessened. We hypothesized that the...